Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 140 financings and $6.8 Billion in aggregate as Lead, Joint, or Co-Manager in 2020
Reverse Merger
Financial Advisor
// to Reshape Lifesciences
June 2021
$55.0 Million
Registered Direct Offering
// Sole Placement Agent
June 2021
$50.0 Million
Initial Public Offering
// Sole Book-Running Manager
June 2021
$407.4 Million
Follow-On Offering
// Co-Manager
June 2021
$12.4 Million
Registered Direct Offering
// Sole Placement Agent
June 2021
$35.0 Million
Private Placement
// Sole Placement Agent
June 2021
$100.0 Million
Initial Public Offering
// Sole Book-Running Manager
May 2021
$14.4 Million
Up-Listing
// Sole Book-Running Manager
May 2021
$13.8 Million
Up-Listing
// Lead Book-Running Manager
May 2021
$30.0 Million
Follow-On Offering
// Sole Book-Running Manager
May 2021
$10.8 Million
Follow-On Offering
// Sole Book-Running Manager
May 2021
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.